​

Funding Round

Series B - BIND Therapeutics

Series B - BIND Therapeutics

Investment Firm

Overview

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

Announced Date

Nov 27, 2007

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant Investor+ND Capital
Participant InvestorARCH Venture Partners
Participant InvestorPolaris Partners
Participant InvestorFlagship Pioneering

Round Details and Background

BIND Therapeutics raised $16000000 on 2007-11-27 in Series B

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 11, 2013
Venture Round - BIND Therapeutics
-8.7M
Feb 13, 2012
Series D - BIND Therapeutics
1-25.5M
Oct 13, 2011
Debt Financing - BIND Therapeutics
-4.8M
Jun 29, 2010
Series C - BIND Therapeutics
5-12.4M

Recent Activity

There is no recent news or activity for this profile.